Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 15
2003 30
2004 26
2005 17
2006 5
2007 4
2008 5
2010 3
2013 1
2015 2
2016 2
2017 1
2020 0
Text availability
Article attribute
Article type
Publication date

Search Results

109 results
Results by year
Filters applied: . Clear all
Page 1
Safety of ephedra: lessons learned.
Soni MG, Carabin IG, Griffiths JC, Burdock GA. Soni MG, et al. Toxicol Lett. 2004 Apr 15;150(1):97-110. doi: 10.1016/j.toxlet.2003.07.006. Toxicol Lett. 2004. PMID: 15068827 Review.
Ergogenic aids: an update on ephedra.
Keisler BD, Hosey RG. Keisler BD, et al. Curr Sports Med Rep. 2005 Aug;4(4):231-5. doi: 10.1007/s11932-005-0042-4. Curr Sports Med Rep. 2005. PMID: 16004835 Review.
Reduction in ephedra poisonings after FDA ban.
Zell-Kanter M, Quigley MA, Leikin JB. Zell-Kanter M, et al. N Engl J Med. 2015 May 28;372(22):2172-4. doi: 10.1056/NEJMc1502505. N Engl J Med. 2015. PMID: 26017843 Free article. No abstract available.
Dilated cardiomyopathy following use of xenadrine EFX.
Riccioni G, Speziale G, Scotti L, Bucciarelli V, Cappetti S, Nasso G, Gallina S, Bucciarelli T. Riccioni G, et al. Int J Immunopathol Pharmacol. 2016 Mar;29(1):137-9. doi: 10.1177/0394632015599701. Epub 2015 Dec 17. Int J Immunopathol Pharmacol. 2016. PMID: 26680256 Free PMC article.
109 results
Jump to page
Feedback